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Accepted 2 September 2020Dietary supplementation with calanus oil, a novel wax ester–richmarine oil, has been shown to
reduce adiposity in high-fat diet (HFD)–induced obese mice. Current evidence suggests that
obesity and its comorbidities are intrinsically linked with unfavorable changes in the intestinal
microbiome. Thus, in line with its antiobesity effect, we hypothesized that dietary supplemen-
tation with calanus oil should counteract the obesity-related deleterious changes in the gut
microbiota. Seven-week-old femaleC57bl/6Jmice receivedanHFD for 12 weeks to induceobesity
followed by 8-week supplementation with 2% calanus oil. For comparative reasons, another
group of mice was treated with exenatide, an antiobesogenic glucagon-like peptide-1 receptor
agonist. Mice fed normal chow diet or nonsupplemented HFD for 20 weeks served as lean and
obese controls, respectively. 16S rRNA gene sequencing was performed on fecal samples from
the colon. HFD increased the abundance of the Lactococcus and Leuconostoc genera relative to
normal chow diet, whereas abundances of Allobaculum and Oscillospira were decreased.
Supplementation with calanus oil led to an apparent overrepresentation of Lactobacillus and
Streptococcus andunderrepresentationofBilophila. Exenatideprevented theHFD-induced increase
in Lactococcus and caused a decrease in the abundance of Streptococcus compared to the HFD
group. Thus, HFDaltered the gutmicrobiota composition in an unhealthy direction by increasing
the abundance of proinflammatory genera while reducing those considered health-promoting.
These obesity-induced changes were antagonized by both calanus oil and exenatide.
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95N U T R I T I O N R E S E A R C H 8 3 ( 2 0 2 0 ) 9 4 – 1 0 71. IntroductionThe role of gut microbiota in human health has received
significant interest in recent years. Alterations in the composition
of the gut microbiome have been associated with obesity and
metabolic disorders, such as insulin resistance and type 2 diabetes
mellitus, thereby increasing the risk for cardiometabolic disease
[1-5]. The causal relationship between alterations in the gut
microbiota and disease development is, however, still unclear,
and it is not fully understood if changes in the microbial
composition occur before or after disease onset [6]. However, it is
known that diet is an important driver behind changes in the gut
microbiota [7-9].
Humans have low ability to synthesize the long-chain omega-3
polyunsaturated fatty acids (PUFA) eicosapentaenoic acid (20:5n-3,
EPA) and docosahexaenoic acid (22:6n-3, DHA). It is therefore
necessary to obtain these essential fatty acids via the diet. Studies
describing the impact of EPA and DHA on the gut microbiota in
humans are relatively sparse. Rajkumar et al. [10] were the first to
study the impact of EPA and DHA on human gut microbiota but
failed to detect anymajor effects on its composition. Later studies
providing omega-3 PUFA supplements to both healthy and obese
individuals revealed similar changes in both groups, such as a
decrease in Faecalibacterium, often associated with an increase in
the Bacteroidetes and butyrate-producing bacteria of the
Lachnospiraceae family [11-13]. Animal studies have also reported
alterations in gut microbiota following dietary supplementation
with marine oils, and interestingly, these alterations in the
microbiome were associated with reductions in body weight gain
and white adipose tissue (WAT) inflammation [14] as well as a
reduced adiposity index [15].
Calanus oil is a novel marine oil extracted from the copepod
Calanus finmarchicus. The oil consists mainly of wax esters, a
lipid class where fatty acids are esterified to long-chain fatty
alcohols [16]. This novel marine oil is, compared to other marine
oils, relatively low in EPA and DHA (6% and 4%, respectively) but
relatively rich in stearidonic acid (18:4n-3, SDA, 7%), the precursor
of EPA and DHA [17,18]. In addition, about 11% of the fatty acids
present in the oil are (long-chain) monounsaturated fatty acids.
Themain fatty alcohols are represented by the equivalents of the
dominant monounsaturated fatty acids, namely, eicosenol
(20:1n-9) and docosenol (22:1n-11) [18].
Digestion and utilization of wax esters are poorly under-
stood [19], although it is evident that humans are able, to
some extent, to hydrolyze waxes and absorb the liberated fatty
acids and alcohols [20]. Furthermore, previous studies in mice
have shown that the wax esters are hydrolyzed and absorbed in
the intestine and that the wax ester–derived fatty acids are
incorporated in liver and WAT [18]. Dietary lipids, such as
triacylglycerol and phospholipids, are quickly digested and
absorbed in the upper parts of the gastrointestinal tract and will
normally not reach the lower part [21].Wax esters are hydrolyzed
by a bile salt–dependent pancreatic carboxyl esterase [20]. They
are relatively hydrophobic and therefore more difficult to
emulsify, and as a result, wax esters may exhibit a longer
retention time [22,23], allowing release of the liberated fatty acid
and fatty alcohols in the distal part of the intestine.
Themousemodel of diet-induced obesity shares many of the
same characteristics as human obesity [24] and has become animportant tool for understanding the pathological mechanisms
involved in obesity-related diseases, such as insulin resistance,
oxidative stress, and liver steatosis [25]. In particular, the
development of a low-grade inflammatory state in obese adipose
tissue and altered adipose tissue metabolism with increased
release of fatty acids are believed to play a central role in the
development of obesity-related pathology.
Previous studies reported that dietary supplementation
with a small amount (2%) of oil from C finmarchicus signifi-
cantly reduced intra-abdominal and ectopic fat deposition in
male mice during high-fat feeding [26,27]. Because obesity is
characterized by unfavorable alterations in the composition
and function of the gut microbiome [4], we hypothesized that
reduced obesity following intake of calanus oil could prevent
or antagonize such alterations of the bacterial composition in
the gut. To test this hypothesis, normal mice were made
obese during a 12-week period on high-fat diet (HFD). This
was followed by 8 weeks of feeding on HFD with or without
2% calanus oil. For comparative reasons, we also included a
group of HFD mice that were treated with the antidiabetic
compound exenatide. This glucagon-like peptide-1 (GLP-1)
receptor agonist also reduces fat deposition in mice during
high-fat feeding [28].2. Methods and materials
2.1. Study design and animals
All animal experiments were approved by the local authority
of the National Animal Research Authority in Norway (FOTS
id 8430). All mice were treated according to the guidelines on
accommodation and care of animals formulated by the
European Convention for the Protection of Vertebrate Ani-
mals for Experimental and Other Scientific Purposes. The
animals were housed at 21°C, 3 animals per cage, under a
reversed light/dark cycle (12-hour dark/12-hour light). The
animals had ad libitum access to food and drinking water, and
body weight and food intake were recorded once a week.
In this study, 4 groups of 5- to 6-week-old C57Bl/6J female
mice (Charles River, Sulzfeld, Germany) were studied (5 mice per
group). The first group served as the lean control group and was
fed a normal chow diet (NCD) containing 10% of energy from fat
(NCD, no. 58Y2, Test Diet; IPS Limited, Richmond, Indiana, USA)
for 20 weeks. The other groups were diet-induced obese by
feeding a lard-based high-fat diet containing 46% of energy from
fat (HFD, no. 58V8, Test Diet; IPS Limited). The second group
received the HFD for 20 weeks. The third and fourth groups
received the HFD for 12 weeks followed by 8 weeks of treatment.
The third group received HFD supplemented with 2% (wt/wt)
commercial Calanus Oil, supplied by Calanus AS, Tromsø,
Norway (HFD + Cal). The addition of the oil was compensated
for by removal of 2 g lard/100 g diet, making the total fat and
energy content of the HFD and the HFD + Cal similar. See Table 1
for a list of ingredients of the different diets and Table 2 for a list
of fatty acid composition of Calanus Oil, the HFD, and the
HFD + Cal. The nutritional profiles of the diets are shown in the
supplementary data. The fourth group was fed HFD and treated
with exenatide, 10 μg/kg/d, via miniosmotic pumps implanted
subcutaneously at the back of the animals (HFD + Ex). After
Table 1 – Ingredient composition in g/kg of the 3
experimental diets
Ingredients NCD HFD HFD + Calanus
Sucrose 331.29 200.92 200.92
Dextrin 298.56 84.83 84.83
Casein, vitamin tested 189.56 233.06 233.06
Powdered cellulose 47.39 58.27 58.27
Maltodextrin 33.17 116.53 116.53
Soybean oil 23.7 29.13 29.13
Lard 18.96 206.84 186.84
Calanus Oil-841 0 0 20
Potassium citrate,
tribasic monohydrate 15.64 19.23 19.23
Calcium phosphate 12.32 15.15 15.15
DIO mineral mix 9.48 11.65 11.65
AIN-76A vitamin mix 9.48 11.65 11.65
Calcium carbonate 5.21 6.41 6.41
L-Cystine 2.84 3.5 3.5
Choline bitartrate 1.9 2.33 2.33
FD&C yellow no. 5 0.5 0 0
FD&C red 40 lake 0 0.5 0
Green dye 0 0 0.5
Total g/kg 1000 1000 1000






NCD, normal control diet (TestDiet 58Y2 with 10% energy from fat);
HFD, high-fat diet (TestDiet 58V8 with 45% energy from fat);
HFD + Cal, high-fat diet with 2% Calanus Oil (TestDiet 58V8 with
2% Calanus Oil). See supplementary materials for details.
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housed to avoid animal interaction, which could damage the
surgical wound.Mice that did not receive pumpswere also single
housed to control for possible effects of single housing.Table 2 – Fatty acid composition (mg/g lipid) of Calanus
Oil and experimental diets
Fatty acids Calanus Oil HFD HFD + Cal
14:0 64.42 10.41 11.95
16:0 45.05 173.65 149.83
18:0 2.42 106.63 92.16
20:0 0.40 1.70 1.37
16:1n-7 17.17 10.95 9.98
18:1n-7 1.53 15.84 13.52
18:1n-9 15.54 243.82 208.42
20:1n-9 24.01 4.74 5.64
20:1n-11 3.90 ND ND
22:1n-9 2.63 ND ND
22:1n-11 43.33 ND 2.20
24:1n-9 2.81 ND ND
18:2n-6 6.64 133.04 116.06
18:3n-3 13.72 12.49 11.67
18:4n-3 69.58 ND 4.54
20:2n-6 0.71 3.15 2.69
20:4n-6 1.39 0.48 1.15
20:5n-3 54.73 ND 3.35
22:5n-3 2.96 ND ND
22:6n-3 39.35 ND 2.81
Modified from Pedersen et al. [18]. ND, not detected.At the end of the feeding experiment, the mice were
killed with an overdose of pentobarbital (100 mg/kg, 300 μL
intraperitoneally). Organs were carefully dissected out and
stored at −80 °C until further analysis. Feces samples were
collected from the colon for microbiota analysis, after which
the gastrointestinal tract was rinsed with saline before
freezing.
2.2. Fatty acid analysis of the colon wall and abdominal fat
Fatty acids were methylated by dissolving 60 mg tissue
sample in 2 mol/L HCl in methanol with 0.05% BHT and
heating for 2 hours at 100 °C, and the fatty acid composition
was determined by gas chromatography using an Agilent
6890N (Agilent Technologies, Santa Clara, CA, USA) gas
chromatograph with a Varian CP7419 capillary column
(Varian Inc, Palo Alto, CA, USA). The content of the individual
fatty acids in the samples was expressed in percent of the
total fatty acid content.
2.3. Quantitative real-time polymerase chain reaction
The expression of mRNA of genes related to inflammation
and fat metabolism in the colon and omental WAT was
determined using quantitative reversed real-time polymerase
chain reaction (PCR). Samples of the intestinal wall (colon,
n = 6-8 per group) were immersed in RNA later (Qiagen,
Hilden, Germany), and WAT samples (n = 6-8 per group)
were immersed in Allprotect Tissue Reagent (Qiagen, Hilden,
Germany) and thawed overnight at 4°C. Thirty to 40 mg colon
tissue and 50-100 mg WAT tissue were used for RNA
extraction according to the Rneasy Lipid Tissue kit Protocol
(Qiagen). RNA concentrations were measured spectrophoto-
metrically (Nanodrop 2000, Thermo Fisher Scientific, Wal-
tham, MA, USA) and stored at −80 °C before use for cDNA.
cDNA was subsequently made from 2 μg total RNA according
to High Capacity cDNA reverse transcriptase kit (Thermo
Fisher Scientific, Waltham, MA, USA). cDNA was stored at −20
°C until real-time PCR (quantitative PCR) was performed in a
Roche LightCycler 96 using a 1:4 dilution of the cDNA and the
fast-start essential DNA green master (Roche, Basel, Switzer-
land). Five housekeeping genes were analyzed to normalize
the expression of the target genes to the geometric mean of
the 2 best housekeeping genes, which were selected on the
basis of the average expression stability values determined
with geNorm. For quantification of the gene expression in the
colon, the housekeeping genes sdha (succinate dehydroge-
nase complex subunit A) and hprt (hypoxanthine-guanine
phosphoribosyl transferase) were used, and for theWAT, sdha
and gapdh (glyceraldehyde-3-phosphate dehydrogenase) were
used. Forward and reverse primers of the target genes
analyzed in the colon and omental fat are shown in Table 3.
2.4. Bacterial DNA isolation
Total microbial DNA was isolated from feces samples with a
QIAamp PowerFecal DNA kit (Qiagen) according to the
manufacturer's protocol, with the following exceptions. The
disintegration of the cells was done with a FastPrep device at
a vortexing speed of 6.5 m/s for 30 seconds followed by
Table 3 – Forward and reverse primers of the target genes analyzed in the intestinal (colon) wall and omental fat
Gene Accession number Primer Melting temperature (°C) Product size
SDHA NM_023281
F: TGT TCA GTT CCA CCC CAC A





F: TCA CCA CCA TGG AGA AGG C





F: TCC TCC TCA GAC CGC TTT T





F: ATG GCA GAC GAT GAT CCC TAC





F: GTG CCG GGA CTG GTC ATT GTG





F: TTG TAC GTG CAA CTC AGG ACT





F: TTG TAC CTA TAC TGT GGC TAA ATG AGA





F: TTA AAA ACC TGG ATC GGA ACC





F: TTC TTC TCC TGC CTG ACA CC





F: CCT GGC CAC AAT GGC ACA CCA





F: ACG ATG CTG TCC TCC TTG ATG





F: GCT GCT GCA GAA GAT GGC A





F: CCA TTC TGG CCC ACC AAC





F: GCC ACC AAT GTT TCC CCC AAT G





F: TGT AAT GAA AGA CGG CAC ACC





F: ATG CCC ACC TCC TCA AAG AC




GLP2R NM_ 175 681.3
F: TCA TCT CCC TCT TCT TGG CTC TTA C





F: CAT GTA CAA AGA CAG TGA AGT AAG AGG





F: GAG CGG GCT ACC TTA CTG AAC





F: TTG GCT TTG CAG CTC TTC CT





F: TTG AAA GTC CAC CTC CTT ACA GA
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incubation were repeated once. The elution was done with
100 μL of elution buffer and stored at −20 °C until used.
2.5. 16S rDNA amplification
Twenty nanograms of DNA was used to prepare PCR
amplicons of the V4-V5 region of 16S rRNA according to
Fliegerova et al. [29]. The mixture contained OneTaq DNA
Polymerase (New England Biolabs, Ipswich, Massachusetts,
USA), and the thermal profile consisted of initial denatur-
ation for 5 minutes at 95 °C followed by 35 cycles of
30 seconds at 95 °C, 30 seconds at 57 °C, and 30 seconds at
72 °C and a final elongation for 5 minutes at 72 °C. The PCR
amplicons were checked by electrophoresis in 1.5% agarose
(25 minutes at 90 V), purified with a QIAquick PCR Purifica-
tion Kit (QIAGEN) according to the protocol, and quantified by
Nanodrop OneC.2.6. Next-generation sequencing
The obtained PCR products were used to prepare amplicon
libraries for diversity analyses by a next-generation sequenc-
ing approach on a Personal Genome Machine (Life Technol-
ogies, Carlsbad, California, USA) according to Milani et al. [30].
Two hundred nanograms of DNA from each sample was used
to prepare sequencing libraries with a NEBNext Fast DNA
Library Prep Set kit (New England Biolabs) according to the
manufacturer's protocol. Ion Xpress Barcode adapters
(Thermo Fisher Scientific) were used to label each sample.
The obtained libraries were used to prepare a sequencing
template by using an Ion PGMTM Hi-QTM View OT2 Kit
(Thermo Fisher Scientific). The template was then sequenced
on an Ion 316TM Chip Kit v2 (Thermo Fisher Scientific) by
using an Ion PGMTM Hi-QTM View Sequencing kit (Thermo
Fisher Scientific). Two independent sequencing runs were
performed.
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The sequences were obtained in the form of the FASTQ format
and further processed by the QIIME2 analyses pipeline [31]. The
sequences were demultiplexed and dereplicated using the
versatile and open-source tool VSEARCH [32]. The bioinformatics
software PICRUSt v 1.1.3 was applied for both the taxonomical
and functional analyses [33]. The sequences were clustered and
identified by performing closed-reference operational taxonomic
unit (OTU) picking selecting a cutoff at 90% sequence identity
against the Greengene reference OTUs (gg_13_5_otus). The
resulting OTU table was normalized using the
normalize_by_copy_number.py script. Functional trait abundance
was predicted using the predict_metagenomes.py script. The
predictions were collapsed into Kyoto Encyclopedia of Genes
andGenomes pathways level 3 using the categorize_by_function.py
script, and the resulting abundance table was imported in the
bioinformatics software STAMP for statistical analysis [34].
Diversity index analysis and unweighted UniFrac distance
metrics analysis [35] were carried out by exporting the QIIME2
biomfile toMicrobiomeAnalyst. TheWebsitemicrobiomeanalyst.
ca was used for visualization of the α diversity index and the heat
map. The absolute and relative abundance tables were exported
and used in STAMP for statistical analysis of the taxonomy data,
in GraphPad prism 8.2.1 for the (stacked) bar graphs, and in
MEGAN Community Edition (version 6.15.2) for visualization of
the principal component analysis.
2.8. Statistical analyses
Data are presented as the means with their standard errors.
Statistical analysis of the functional and taxonomic data was
done using STAMP [34]. Noncorrected 2-sided Student t test
between the HFD group and the other three groups was done to
check for significant differences vs the HFD group (n = 5 for each
group). Mean differences were considered significant at P < .05.
Statistical analysis on the gene sequencing was done in
GraphPad prism 8.2.1. Differences between treatment groups
were assessed by 1-way analysis of variance followed by Dunnet
post hoc test where the groups were compared to the HFD group
(n = 6-8 for each group). Sample sizes were determined based on
availability of the samples because this study was ran in parallel
to another study using the samemice [36].3. Results
3.1. Body weight gain and fatty acid composition of the
diets, and abdominal fat and colon wall
The present microbiota data were obtained on a subgroup of
mice (n = 5) used in a recent publication by Jansen et al. [36].
Details about body weight development, weight of adipose
tissue, and food intake are given in that publication. Here it is
just pointed out that supplementation of the HFD with oil
from C finmarchicus for the last 8 weeks did not affect body
weight gain (Fig. 1), although it did result in a lower adiposity
index (total weight of intra-abdominal fat depots) relative to
the nonsupplemented HFD group. Treatment with exenatide,
however, led to both lower weight gain (Fig. 1) and loweradiposity index. Of note, both treatments recovered the
capacity of the heart to oxidize glucose, which was otherwise
impaired in response to high-fat feeding [36], demonstrating
that both the wax ester–rich oil and exenatide recovered
metabolic flexibility of hearts from diet-induced obese mice.
There were no differences in food intake between the diet
groups during the treatment period [36]. The inclusion of 2%
calanus oil in the HFD resulted in clearly detectable amounts
of SDA, EPA, and DHA in this diet (Table 2). Analysis of the
fatty acid composition of abdominal fat showed a statistically
significant increase in the content of n-3 PUFA (SDA, DHA,
and EPA), whereas the content of arachidonic acid (n-6 PUFA)
was significantly reduced (Table 4). In the colon wall, the
content of SDA was significantly increased (P < .05) in the
HFD + Cal group relative to that of the HFD group (0.89% ±
0.23% vs 0.63% ± 0.07%), but for the other PUFA, the variability
was too high to reach firm conclusions (data not shown).
3.2. Microbiota composition of feces samples from colon
The average sequence count over all 20 samples was 6761
sequence reads per sample. The average species diversity, or α
diversity, within the 4 diet groups was measured using the
Shannon Phylogenetic Diversity index on the OTU level (Fig. 2).
No statistically significant differences were observed between
the groups (P = .0596, Kruskal-Wallis statistics: 7.4229).
The β diversity, the difference between the diet groups, is
presented through a principal coordinate analysis based on
unweighted UniFrac distances (Fig. 3). The first and second
principal coordinates are given. Axis 1 explains 43.7% of the
variation, and axis 2 explains 22.6%. Distinct clusters separate
the NCD and HFD + Ex groups. The HFD and HFD + Cal groups
overlap, with the HFD + Cal group having a larger cluster than
the HFD group.
Fig. 4A illustrates the relative abundance of the different
bacterial phyla for each diet group. Firmicutes was the most
abundant phylum in all 4 groups, followed by Bacteroidetes.
There were no apparent differences in the relative abundance
on the phylum level. But there were significant differences on
the genus level as highlighted in Fig. 4B. It is obvious that the
HFD and HFD + Cal groups share a similar bacterial profile,
whereas the profiles of the HFD + Ex and NCD groups are
different compared to HFD. To illustrate the relative abun-
dance of the various genera in more detail, we also generated
bar graphs ± standard error of the mean in Fig. 5. The most
abundant genera in the feces samples were Allobaculum,
Lactobacillus, Lactococcus, Turicibacter, and Parabacteroides. On
first sight, it seemed that the main effect of HFD is a marked
decline in Allobaculum and the presence of Lactococcus relative
to the NCD group. Dietary supplementation with calanus oil
did not seem to influence these HFD-induced changes in the
microbiota composition, except for an apparently further
decline in Allobaculum and an increased abundance of
Lactobacillus. Treatment with exenatide reduced the high
abundance in Lactococcus present in the HFD group. Turicibacter
was abundant in all diet groups but mostly in the NCD and
HFD + Ex group, whereas the presence of Parabacteroides
seemed to be independent of diet.
A noncorrected 2-sided Student t test (comparing HFD vs
NCD, HFD vs HFD + Cal, and HFD vs HFD + Ex) revealed that,
Fig. 1 – Bodyweight gain for the four different diet groups. Data are shown asmeans ± SEM. After 8 weeks of treatment, the weight
gain of NCD and HFD + Ex groups was significantly different from HFD (P < .05).
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in the HFD compared to the NCD are significantly different, as
was the increase in Leuconostoc (Fig. 6A). There were no
significant differences between the HFD and HFD + Cal
group. The apparent decrease in Lactococcus in the exenatide-
treated group compared to the HFD group was significantly
different, as well as the decrease in Streptococcus (Fig. 6B).
It is currently unknown at what abundance threshold
certain gut bacteria lead to an increased disease risk. A
statistical difference might therefore not necessarily lead to
pathology or health improvement. Therefore, we visualize in
Fig. 7 the differences of the various genera for each individual
fecal sample in more detail with a heat map. Difference in
colored tiles represents the multiplication of abundance of
the genera, per sample, compared to the average abundance
of those genera of all 20 fecal samples.Table 4 – Content of PUFA in % of total fatty acid content in
intra-abdominal fat from the various groups of mice
SDA DHA EPA AA
NCD 0.78 ± 0.15 0.26 ± 0.17 ND 0.42 ± 0.12
HFD 0.65 ± 0.03 0.19 ± 0.03 ND 0.40 ± 0.04
HFD + Cal 1.09 ± 0.12 a 0.74 ± 0.10 a 0.19 ± 0.04 a 0.30 ± 0.04
HFD + Ex 0.71 ± 0.09 0.23 ± 0.04 ND 0.44 ± 0.09
Results are mean ± SD (n = 5 in each group).
a P < .05 vs HFD.Some genera showed large variation in abundance within
the diet groups (Bacteroides, Parabacteroides, Lactobacillus,
Akkermansia, Adlercreutzia, Coprococus, Blautia, Turicibacter,
Bilophila), whereas the abundance was more stable for other
genera (Lactococcus, Lauconostoc, Allobaculum, Ruminococcus,
Streptococcus, Dorea, Oscillospira). Thus, in line with the relative
abundance shown in Fig. 5, the heat map shows that
Lactococcus, Leuconostoc, and Streptococcus were above average
present in the HFD and HFD + Cal groups, whereas Dorea and
Ruminococcus were below average present in these groups.
Allobaculum and Oscillospirawere below average present in the
3 groups feeding on an HFD. Moreover, feces samples from the
majority of mice in the HFD + Cal groupwere characterized by
overrepresentation of Lactobacillus and Streptococcus and un-
derrepresentation of Bilophila. In the HFD + Ex group, over-
representation of Ruminococcus was particularly evident.
3.3. Metagenomic functional prediction
The 16S rRNA gene was used as a marker gene to extrapolate
the taxonomic findings into functional predictions. The
taxonomic information from screening samples against the
Greengenes reference database was used to extract informa-
tion from the complete genome sequences of the identified
species. Combining whole genome information together with
abundance measures for each species allowed for the
prediction and quantification of functional pathways. Statis-
tical analysis of the Kyoto Encyclopedia of Genes and
Genomes data identified in total 328 genes related to
Fig. 2 – α diversitymeasured as Shannon Phylogenetic Index onOUT level for the 4 different diet groups. Therewere no statistically
significant changes in the α diversity between the groups. (P = .0596, Kruskal-Wallis statistics: 7.4229).
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icant differences in the relative abundance of the predicted
microbial genes (based on the noncorrected 2-sided Student t
test) revealed the difference in the mean proportions of these
genes between the HFD andNCD groups, the HFD and HFD + Cal
groups, and theHFD and theHFD + Ex groups (Figs. 8A-C). As can
be seen in Fig. 8A, 38 categories were differently expressed in the
HFD vs NCD groups. Relevant for the current study was the
overexpression of lipid and fatty acid biosynthesis proteins in the
gutmicrobiota of the HFD-fedmice. Fig. 8B gives the 7 functional
categories that were differently present in the colonicmicrobiota
in the HFD and HFD + Cal groups. The novel marine oilFig. 3 – Principle coordinate analysis based on unweighted UniFrac
individual mice. Percent variation explained by the principal coord
squares, NCD; blue diamonds, HFD; green triangles, HFD + Cal; oraupregulated 4 of the 7 categories in the high-fat–fed mice,
which included proteins related to glycolysis, gluconeogenesis,
and phosphate transferase systems (Fig. 8B). Ten categories
where differently expressed in the microbiota of the HFD vs the
HFD + Ex group (Fig. 8C). With respect to metabolic control, we
note that proteins involved in glycine, serine, and threonine
metabolism were overexpressed in the HFD + Ex group.
3.4. Gene expression
The gene expression of several markers for inflammation, fat
storage regulation, and permeability of the intestinal wallin mice fed different diets. The symbols indicate values for
inates PC 1 and PC 2 was 43.7% and 22.6%, respectively. Red
nge circles, HFD + Ex.
Fig. 4 – Relative abundance at the phyla (A) and genera levels (B) in the 4 diet groups.
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TNF-α, CD36, EMR1a, adiponectin TLR4, MCP1, NF-κB, FIAF,
PPARα, PPARβ, PPARγ, and GLP2 R) and the colon (GPR41,
GPR43, GPR120, TNF-α, MUC2, GLP2 R, IL-1β, Il-10, IL-18, IFN-γ,Fig. 5 – Relative abundanceof thedifferent generapresent in colon feFIAF, ZO-1, occluding, TLR4, and NF-κB). None of the analyzed
genes were up- or downregulated depending on diet in the 2
tissues, with the exception of adiponectin (see also Supple-
mentary Figs. S1 and S2).ces samples fromthe4diet groups.Data shownasmeans±SEM.
Fig. 6 – Comparison of mean proportion of bacterial genera. (A) HFD vs NCD groups. (B) HFD vs HFD + Ex groups. Only statistically
significant differences (P < .05, noncorrected 2-sided Student t test) are shown.
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Diet has long been considered the most important driver
behind changes in the intestinal microbiota [7-9]. In thisFig. 7 – Heat map showing the representation of the different gene
abundance of those genera. The multicolored bar at the top deline
indicated at the bottom of the heatmap. The colored tiles indicate a
dark blue) of the genus average across all individual samples.study, we show that long-term feeding on a HFD led to an
increase in the intestinal abundance of the bacterial genera
Lactococcus and Leuconostoc, whereas the abundance of
Allobaculum and Oscillospira was decreased. Supplementation
of the HFD with 2% of wax ester–containing oil from Cra in each individual fecal sample compared to the average
ates the 4 diet groups, whereas the individual samples are
positive (light to dark brown) or negativemultiplication (light to
Fig. 8 – Comparison of mean proportion of predicted microbial genes present in colonic samples related to functional categories of
(A) HFD vs NCD, (B) HFD vs HFD + Cal, and (C) HFD vs HFD + Ex. Only significant (P < .05) functional pathways are shown based on a
noncorrected 2-sided Student t test. The colored circles represent the difference in mean proportions of the various functional
categories with the 95% confidence interval, as calculated using bootstrap method.
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104 N U T R I T I O N R E S E A R C H 8 3 ( 2 0 2 0 ) 9 4 – 1 0 7finmarchicus did not alter this pattern significantly, although it
led to an overrepresentation of Lactobacillus and Streptococcus
and underrepresentation of Bilophila. Administration of the
GLP-1 analog exenatide prevented the HFD-induced increase
in Lactococcus, and in addition, it caused a decrease in the
abundance of Streptococcus.
The high relative abundance of Lactococcus and the near
depletion of Allobaculum in the HFD group are in agreement
with previous animal studies [8,9]. Lactococcus is associated
with proinflammatory markers [8,13,15], whereas Allobaculum
is a short-chain fatty acid–producing bacterium which is
considered health-promoting. Therefore, HFD used in the
current study seems to change the microbiota composition in
an unhealthy direction. This view was further supported by
the finding that Oscillospira, a genus of importance for human
health [37] and which has been reported to correlate
negatively with body mass index and paracellular permeabil-
ity in humans [38], was depleted in nearly all HFD mice.
Dietary fat has been shown to modulate gut microbiota [39],
and to our knowledge, this is the first study investigating the
effect of the oil from C finmarchicus on gut microbiota. As
mentioned in the introduction, this marine oil contains more
than 85% wax esters, consisting of saturated, monounsaturated,
and polyunsaturated fatty acids bound to long-chain fatty
alcohols. The general view is that the omega-3 fatty acids EPA
and DHA represent the active substance in marine oil prepara-
tions, but the high content of SDA (7%) and fatty alcohols (about
350 mg/g),which is unique for this novelmarine oil, could also be
beneficial for human health, [40]. To which extent this fatty acid
and fatty alcohols affect the composition of the gutmicrobiota is,
to our knowledge, not known.
Supplementing HFD with 2% calanus oil was not able to
restore the microbiota composition to that of the NCD group.
Nevertheless, the relative abundance of Lactobacillus and
Streptococcus was above average in the majority of the mice
receiving the marine oil. This observation is in line with
results by Caesar et al. [14], who reported increased abun-
dance of Lactobacillus and Streptococcuswhen they replaced the
lard in the high-fat diet with fish oil (Menhaden oil). Our
results are also in line with findings by Mujico et al [41], who
observed an increase in Lactobacillus following supplementa-
tion of HFD with EPA and DHA in female mice. Caesar et al. [
14] reported reduced body weight gain and reduced inflam-
mation due to an interaction between dietary lipids and the
microbiota, which reduced toll-like receptor 4 (TLR4)–induced
secretion of monocyte chemoattractant protein-1 (MCP-1/
CCL2). Unlike the study by Caesar et al. (2015), we did not
detect any differences between the groups with respect to
WAT or colon gene expression of MCP-1, TLR4, and other
inflammatory markers, which could be due to a relatively
short treatment period with the marine calanus oil used in
the present study. We observed an antiobesogenic effect of
the wax ester–rich oil in terms of a reduced adiposity index.
The mice did not, however, show a clear reduction in body
weight development, as seen in previous experiments [26,27],
and this could be due to a relatively short treatment period (8
vs 27 weeks). In addition, it should be noted that we used
female mice in the current experiment and therefore cannot
exclude gender differences with respect to the response of the
marine oil supplementation. We did however observe anincreased level of n-3 PUFA (and decline in n-6 PUFA) in intra-
abdominal fat of mice receiving HFD supplemented with
calanus oil, which is in line with previous results [18] and
demonstrates very clearly that the wax ester in the oil is
digested in the intestine is taken up, and thereby contributes
to a healthier adipose tissue. In light of the role of omega-3
fatty acids as PPAR ligands [42] and the consequent activation
of gene transcription, it was a bit surprising that the reduced
adiposity index following calanus oil supplementation was
not reflected in any significant change in PPAR expression in
adipose tissue. One possibility could be that PPARα was
upregulated primarily in metabolically active tissues, such
as liver, heart, and skeletal muscle, leading to increased fatty
acid oxidation and thereby draining of fatty acids from WAT.
The increasedabundanceof Lactobacillusmight beof biological
relevance because it is considered a health-promoting, short-
chain fatty acid–producing probiotic strain that is often associ-
ated with weight loss, regulation of fat metabolism, and anti-
inflammation (as reviewed in [13] and [43]). Most species of
Streptococcus are considered pathogenic, but, for example, Strep-
tococcus thermophilus is a probiotic. Unfortunately, our analysis
was not capable of distinguishing between the different species
of this genus, so the impact of the increased abundance of
Streptococcus is not clear. Caesar et al. [14] also found a lower
abundance of Bilophila in the fish oil–fed mice compared to the
lard-fed mice. Interestingly, all 5 animals fed HFD + Cal in the
current study also showed a below average abundance of
Bilophila. This genus is shown to increase upon consumption of
diets rich in saturated animal fats, and increased abundance of
Bilophila wadsworthia is associated with inflammatory bowel
disease [44]. To find out if the decreased adiposity index in
response to dietary oil, as observed in the present study, was due
to an enrichment of Lactobacillus and/or depletion of Bilophila, a
larger study needs to be done.
In recent years, the effect of antidiabetic drugs on the gut
microbiota has received more and more attention both in
humans and in animal models. For example, it is known that
themost used antidiabetic drug,metformin, aswell as different
α-glucosidase inhibitors (acarbose, miglitol, and voglibose),
alters the composition of the gut microbiota [45,46]. A few
studies examined the effect of liraglutide which, like exenatide,
is a GLP-1 receptor agonist [47-49]. Treatment with liraglutide
was associated with an increase in Blautia and Turicibacter,
whereas the effect on Allobaculum and Lactobacillus was less
clear and dependent on the animal model in question [47,48].
Wang et al. [47] found that liraglutide-induced weight loss was
associated with, among others, Lactobacillus, Turicibacter,
Coprococcus, and Blautia. The exenatide-treated mice in our
study showeddecreased bodyweight and fatmass compared to
the HFD mice, and in line with Wang et al. [47], we observed a
slight increase in the abundance of Turicibacter in this group.
However, we did not observe any effect of exenatide on the
other “weight reducing” bacteria. Interestingly, exenatide
seemed to reduce the abundance of Streptococcus and
Lactococcus, which are considered pathogenic, while increasing
the abundance of Ruminococcus and Dorea. The latter 2 genera
are generally related to insulin resistance and disturbed
metabolic health [50,51]. In addition, De Filippis et al. [52]
found a correlation between Ruminococcus and trimethylamine
N-oxide levels, a microbiota-dependent metabolite derived
105N U T R I T I O N R E S E A R C H 8 3 ( 2 0 2 0 ) 9 4 – 1 0 7from trimethylamine-containing nutrients that are abundant
in aWestern diet and has been associated with obesity, insulin
resistance, and increased thrombosis potential in animal and
clinical studies [53]. Thus, the previously reported improve-
ment in insulin sensitivity following exenatide treatment [28]
could imply the effect of reduced abundance of Streptococcus
and Lactococcus overrides that of the increase in Ruminococcus
and Dorea.
It is currently unknown how GLP-1 receptor agonists
induce alterations in the microbiota profile, but changes in
pH and nutrient composition in the gut, as well as delay in gut
transit time and gastric emptying rate, could be involved [47].
Another proposed mechanism is via the interplay with bile
acids [51]. GLP-1 receptor agonists are suggested to induce
weight loss via reduced food intake due to inhibition of
appetite and reduced gastric emptying. In our study however,
we could not detect any difference in food intake between the
HFD-fed groups. We therefore suggest that weight loss in
response to exenatide treatment could be due to a re-
establishment of the abundance of Lactococcus, Leuconostoc,
Streptococcus, Turicibacter, Dorea, and Ruminococcus which
characterized the lean NCD group.
Functional analysis of the gut microbiota revealed signif-
icant changes between the NCD- and the HFD-fed mice. Mice
fed an HFD had increased abundance of bacteria with capacity
for lipid and fatty acid biosynthesis, that is, substrates which
could become available as nutrients or bioactive compounds
for the host and explain the observed increase in body weight
and adiposity index in this group. The microbial composition
of the HFD + Cal group was associated with increased
activities of the phosphotransferase system, glycolysis, and
gluconeogenesis compared to the HFD mice. These 2 func-
tions enable the bacteria to take up and metabolize carbohy-
drates, producing metabolites which could potentially be
used by the host. To determine if this is related to the reduced
adiposity index in the mice fed oil from C finmarchicus, a
further in-depth study is needed. Functional analysis of the
microbiota from HFD + Ex mice showed upregulation of
signal transduction pathways, but the implication of this
observation also needs further studies.
This is the first study examining the effect of calanus oil, a
wax ester–containing oil derived from C finmarchicus, on the
gut microbiota composition. Obesity in female mice was
associated with an enrichment of the proinflammatory
Lactococcus and a depletion of the anti-inflammatory and
health-promoting Allobaculum and Oscillospira, changing the
microbiota composition in an unhealthy direction. Although
dietary oil from C finmarchicus was not able to restore the
microbiota composition to that of the lean control group, it
resulted in a relatively high abundance of Lactobacillus, a
health-promoting genus, which is often related to weight loss.
It also reduced the abundance of the pathogenic Bilophila
genus. Treatment with exenatide partly restored the bacterial
profile found in the lean control group and seemed to
reduce the abundance of Streptococcus and Lactococcus, which
are both considered pathogenic. These data confirm our
hypothesis, namely, that dietary supplementation with the
antiobesogenic calanus oil is able to antagonize the unfavor-
able changes in the gut microbiota induced by high-fat
feeding.Differences in sample preservation and DNA extraction,
library preparation, as well as use of different reference
databases or software programs make it difficult to compare
results from one laboratory to another [54-56]. In this study,
the number of animals in each group was relatively small
(n = 5), and hence, the power of the statistical analysis was
relatively low. In addition, determination of the microbiota
composition was based only on feces samples from the colon.Acknowledgment
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